Literature DB >> 33446850

The role of Toll-like receptor 9 in a murine model of Cryptococcus gattii infection.

Elias Barbosa da Silva-Junior1, Luan Firmino-Cruz1,2, Joyce Cristina Guimarães-de-Oliveira1, Juliana Valente Rodrigues De-Medeiros1,2, Danielle de Oliveira Nascimento3, Matheus Freire-de-Lima1, Lycia de Brito-Gitirana4, Alexandre Morrot2,5, Jose Osvaldo Previato1, Lucia Mendonça-Previato1, Debora Decote-Ricardo6, Herbert Leonel de Matos Guedes7,8, Celio Geraldo Freire-de-Lima9.   

Abstract

Toll-like receptor 9 (TLR9) is crucial to the host immune response against fungi, such as Candida albicans, Aspergillus fumigatus and Cryptococcus neoformans, but its importance in Cryptococcus gattii infection is unknown. Our study aimed to understand the role of TLR9 during the course of experimental C. gattii infection in vivo, considering that the cryptococcal DNA interaction with the receptor could contribute to host immunity even in an extremely susceptible model. We inoculated C57BL/6 (WT) and TLR9 knock-out (TLR9-/-) mice intratracheally with 104 C. gattii yeast cells. TLR9-/- mice had a higher mortality rate compared to WT mice and more yeast cells that had abnormal size, known as titan cells, in the lungs. TLR9-/- mice also had a greater number of CFUs in the spleen and brain than WT mice, in addition to having lower levels of IFN-γ and IL-17 in the lung. With these markers of aggressive cryptococcosis, we can state that TLR9-/- mice are more susceptible to C. gattii, probably due to a mechanism associated with the decrease of a Th1 and Th17-type immune response that promotes the formation of titan cells in the lungs. Therefore, our results indicate the participation of TLR9 in murine resistance to C. gattii infection.

Entities:  

Year:  2021        PMID: 33446850      PMCID: PMC7809259          DOI: 10.1038/s41598-021-80959-5

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  59 in total

1.  Structure and antigenic activity of the capsular polysaccharide of Cryptococcus neoformans serotype A.

Authors:  R Cherniak; E Reiss; M E Slodki; R D Plattner; S O Blumer
Journal:  Mol Immunol       Date:  1980-08       Impact factor: 4.407

2.  Pulmonary infection with an interferon-gamma-producing Cryptococcus neoformans strain results in classical macrophage activation and protection.

Authors:  Sarah E Hardison; Sailatha Ravi; Karen L Wozniak; Mattie L Young; Michal A Olszewski; Floyd L Wormley
Journal:  Am J Pathol       Date:  2010-01-07       Impact factor: 4.307

3.  Capsular polysaccharides galactoxylomannan and glucuronoxylomannan from Cryptococcus neoformans induce macrophage apoptosis mediated by Fas ligand.

Authors:  Suellen N Villena; Roberta O Pinheiro; Carla S Pinheiro; Marise P Nunes; Cristina M Takiya; George A DosReis; José O Previato; Lucia Mendonça-Previato; Célio G Freire-de-Lima
Journal:  Cell Microbiol       Date:  2008-01-30       Impact factor: 3.715

4.  Fungal cell gigantism during mammalian infection.

Authors:  Oscar Zaragoza; Rocío García-Rodas; Joshua D Nosanchuk; Manuel Cuenca-Estrella; Juan Luis Rodríguez-Tudela; Arturo Casadevall
Journal:  PLoS Pathog       Date:  2010-06-17       Impact factor: 6.823

5.  Cryptococcal cell morphology affects host cell interactions and pathogenicity.

Authors:  Laura H Okagaki; Anna K Strain; Judith N Nielsen; Caroline Charlier; Nicholas J Baltes; Fabrice Chrétien; Joseph Heitman; Françoise Dromer; Kirsten Nielsen
Journal:  PLoS Pathog       Date:  2010-06-17       Impact factor: 6.823

Review 6.  Cryptococcosis: epidemiology, fungal resistance, and new alternatives for treatment.

Authors:  F P Gullo; S A Rossi; J de C O Sardi; V L I Teodoro; M J S Mendes-Giannini; A M Fusco-Almeida
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-07-04       Impact factor: 3.267

7.  Early or late IL-10 blockade enhances Th1 and Th17 effector responses and promotes fungal clearance in mice with cryptococcal lung infection.

Authors:  Benjamin J Murdock; Seagal Teitz-Tennenbaum; Gwo-Hsiao Chen; Anthony J Dils; Antoni N Malachowski; Jeffrey L Curtis; Michal A Olszewski; John J Osterholzer
Journal:  J Immunol       Date:  2014-09-15       Impact factor: 5.422

8.  Lung-infiltrating T helper 17 cells as the major source of interleukin-17A production during pulmonary Cryptococcus neoformans infection.

Authors:  Elaheh Movahed; Yi Ying Cheok; Grace Min Yi Tan; Chalystha Yie Qin Lee; Heng Choon Cheong; Rukumani Devi Velayuthan; Sun Tee Tay; Pei Pei Chong; Won Fen Wong; Chung Yeng Looi
Journal:  BMC Immunol       Date:  2018-11-08       Impact factor: 3.615

9.  Titan cells formation in Cryptococcus neoformans is finely tuned by environmental conditions and modulated by positive and negative genetic regulators.

Authors:  Benjamin Hommel; Liliane Mukaremera; Radames J B Cordero; Carolina Coelho; Christopher A Desjardins; Aude Sturny-Leclère; Guilhem Janbon; John R Perfect; James A Fraser; Arturo Casadevall; Christina A Cuomo; Françoise Dromer; Kirsten Nielsen; Alexandre Alanio
Journal:  PLoS Pathog       Date:  2018-05-18       Impact factor: 6.823

10.  IFN-γ immune priming of macrophages in vivo induces prolonged STAT1 binding and protection against Cryptococcus neoformans.

Authors:  Chrissy M Leopold Wager; Camaron R Hole; Althea Campuzano; Natalia Castro-Lopez; Hong Cai; Marley C Caballero Van Dyke; Karen L Wozniak; Yufeng Wang; Floyd L Wormley
Journal:  PLoS Pathog       Date:  2018-10-10       Impact factor: 6.823

View more
  2 in total

Review 1.  Cryptococcus spp. and Cryptococcosis: focusing on the infection in Brazil.

Authors:  Fabíolla Nacimento do Carmo; Juliana de Camargo Fenley; Maíra Terra Garcia; Rodnei Dennis Rossoni; Juliana Campos Junqueira; Patrícia Pimentel de Barros; Liliana Scorzoni
Journal:  Braz J Microbiol       Date:  2022-04-29       Impact factor: 2.214

2.  X-linked immunodeficient (XID) mice exhibit high susceptibility to Cryptococcus gattii infection.

Authors:  Israel Diniz-Lima; Pablo Rodrigo da Rosa; Elias Barbosa da Silva-Junior; Joyce Cristina Guimarães-de-Oliveira; Elisangela Oliveira de Freitas; Danielle de Oliveira Nascimento; Alexandre Morrot; Leonardo Nimrichter; Jose Osvaldo Previato; Lucia Mendonça-Previato; Leonardo Freire-de-Lima; Debora Decote-Ricardo; Celio Geraldo Freire-de-Lima
Journal:  Sci Rep       Date:  2021-09-15       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.